ubrogepant
Treatment for Cluster Headache
Ubrogepant is a selective calcitonin gene-related peptide (CGRP) receptor antagonist that blocks CGRP signaling, which plays a crucial role in migraine and cluster headache pathogenesis. By inhibiting the CGRP receptor, ubrogepant reduces neurogenic inflammation and pain transmission, providing therapeutic relief for acute cluster headache episodes.